News

Public · Published

Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division

Addus HomeCare reported third-quarter adjusted earnings per share of $1.83, above the $1.80 analyst estimate, while service revenue rose 7% year over year. The company said it plans to acquire AccentCare's personal care division, which it expects to expand its revenue base by nearly 19%.

Published:

Updated:

What happened

Addus HomeCare reported third-quarter adjusted earnings per share of $1.83, above the $1.80 analyst estimate, while service revenue rose 7% year over year. The company said it plans to acquire AccentCare’s personal care division, which it expects to expand its revenue base by nearly 19%.

Confirmed

Global impact / market context

The reported growth across personal care, hospice and home health suggests several services contributed, rather than growth depending on one area. If completed, the acquisition could add revenue and scale, while integration costs and execution will determine how much of that growth reaches profit and cash available.

Analyst inference

The article describes a company combining organic volume growth, rate adjustments and acquisition contributions, while also pursuing further deals. Its stated plan to integrate AccentCare in coming quarters makes delivery on timing and profitable growth through 2026 relevant to assessing the expansion strategy.

Analyst inference

What to watch

  1. Whether Addus closes the AccentCare personal care acquisition in the coming quarters, as expected, and whether the added business produces the nearly 19% revenue-base expansion described. Confirmed
  2. How the company integrates AccentCare and whether its personal care, hospice and home health operations continue growing without integration costs weakening profit or cash generation. Analyst inference
  3. Whether Addus pursues further acquisitions to build market density and operational scale, and whether management continues to anticipate profitable growth through the end of 2026. Confirmed

Evidence

  • Original source link unavailable